I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Pharmacokinetics and Safety of CT-P17 (40 mg/0.4 ml) Versus..:
Haranaka, Miwa
;
Tanaka, Takanori
;
Kim, SungHyun
...
Immunotherapy. 15 (2023) 3 - p. 149-161 , 2023
Link:
https://doi.org/10.2217/imt-2022-0181
RT Journal T1
Pharmacokinetics and Safety of CT-P17 (40 mg/0.4 ml) Versus Reference Adalimumab: Randomized Study in Healthy Japanese Adults
UL https://suche.suub.uni-bremen.de/peid=cr-10.2217_imt-2022-0181&Exemplar=1&LAN=DE A1 Haranaka, Miwa A1 Tanaka, Takanori A1 Kim, SungHyun A1 Bae, YunJu A1 Jeon, DaBee A1 Choi, EunJin A1 Cha, JungBin A1 Lee, SangMi A1 Ogama, Yoichiro PB Informa UK Limited YR 2023 SN 1750-743X SN 1750-7448 JF Immunotherapy VO 15 IS 3 SP 149 OP 161 LK http://dx.doi.org/https://doi.org/10.2217/imt-2022-0181 DO https://doi.org/10.2217/imt-2022-0181 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)